To further demonstrate the role of CNOT4 in anti‐PD‐1 mediated immunotherapy in lung cancers, we used a tumor‐bearing model, in which control or CNOT4‐overexpression (CNOT4‐OE) A549 cells were subcutaneously implanted into C57BL/6 mice. Here, CNOT4 is linked to lung carcinoma.